• IEM 1460: Redefining AMPA Blockade for Translational Neuropr

  2026-04-24

  This article explores the mechanistic and translational impact of IEM 1460, a selective AMPA receptor blocker, in the context of excitotoxicity, neuroprotection, and advanced assay design. By integrating new evidence from glutamate receptor antagonism and highlighting best practices for translational researchers, it delivers actionable guidance and strategic perspective beyond conventional product literature.

• SLU-PP-332: ERRα/β/γ Agonist and Mitochondrial Biogenesis Ac

  2026-04-23

  SLU-PP-332 is a synthetic ERRα ERRβ ERRγ agonist that robustly stimulates mitochondrial biogenesis and enhances muscle endurance. Peer-reviewed studies confirm nanomolar potency for ERR activation and significant exercise-mimetic effects in vivo. APExBIO supplies SLU-PP-332 as a research-grade, orally bioavailable tool for metabolic and translational research.

• 7ACC2: Potent Monocarboxylate Transporter 1 Inhibitor in Can

  2026-04-23

  7ACC2 is a potent monocarboxylate transporter 1 inhibitor that blocks lactate uptake and mitochondrial pyruvate transport in cancer cells. It demonstrates nanomolar efficacy and dual-acting mechanisms, making it a valuable tool for cancer metabolism research and tumor growth delay studies. All claims are substantiated with peer-reviewed and product-sourced evidence.

• Annexin V, human recombinant: Reliable PS Binding for Apopto

  2026-04-22

  This scenario-driven article addresses common laboratory challenges in apoptosis detection, focusing on how Annexin V, human recombinant (SKU K2064) from APExBIO provides reproducible and data-backed solutions. By grounding every recommendation in evidence—from protocol parameters to vendor selection—this guide optimizes both experimental confidence and workflow efficiency for cell death research.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor–S

  2026-04-22

  This study introduces a patient-specific gastric cancer assembloid model that integrates tumor organoids with matched stromal cell subpopulations, closely recapitulating the complexity of the tumor microenvironment. The model reveals how stromal components influence gene expression and drug responses, providing an advanced platform for investigating resistance mechanisms and optimizing personalized therapies.

• PP2A-Driven Autophagy Modulates Candida albicans Biofilm Res

  2026-04-21

  This study establishes that protein phosphatase 2A (PP2A) modulates drug resistance in Candida albicans biofilms by influencing autophagy through ATG protein phosphorylation. The findings highlight a mechanistic link between PP2A activity, biofilm robustness, and antifungal treatment efficacy, offering new avenues for overcoming persistent Candida infections.

• Polymyxin B Sulfate in Precision Immunology: Bridging Infect

  2026-04-21

  Explore how Polymyxin B sulfate, a potent antibiotic, is redefining precision immunology through its dual role in infection research and immune modulation. Discover novel insights that link Gram-negative bacterial targeting to cancer immunotherapy outcomes.

• Perphenazine (SKU B6157): Reliable D2 Antagonist for Cell As

  2026-04-20

  This article guides biomedical researchers through the practical deployment of Perphenazine (SKU B6157) in cell viability, proliferation, and cytotoxicity assays. Using scenario-driven Q&A, it addresses key workflow decisions, protocol optimization, and product selection, offering literature-backed recommendations and protocol parameters to ensure reproducibility and experimental clarity.

• METTL16-SENP3-LTF Axis Regulates Ferroptosis in HCC Progress

  2026-04-20

  Wang et al. identify a novel METTL16-SENP3-LTF signaling axis that suppresses ferroptosis and facilitates hepatocellular carcinoma (HCC) progression by modulating iron metabolism and m6A RNA modification. These findings highlight a potential therapeutic target for sensitizing HCC cells to ferroptosis-based interventions.

• CPI-613: Applied Strategies in Tumor Cell Metabolism Researc

  2026-04-19

  CPI-613 (6,8-bis(benzylsulfanyl)octanoic acid) empowers researchers to dissect mitochondrial metabolism and apoptosis in cancer models with precision. This guide reveals optimized workflows, key troubleshooting insights, and actionable protocol parameters for maximizing experimental success in apoptosis assays and tumor cell metabolism studies.

• ML385 and NRF2 Inhibition: Precision Tools for Redox Biology

  2026-04-18

  Explore how ML385, a selective NRF2 inhibitor, empowers advanced research into redox signaling, ferroptosis, and therapeutic resistance. Discover unique assay insights and practical protocol guidance informed by the latest scientific findings.

• Lanabecestat (AZD3293): BACE1 Inhibitor for Alzheimer’s Rese

  2026-04-17

  Lanabecestat (AZD3293) is a potent, selective, orally active BACE1 inhibitor widely used in Alzheimer’s disease research. Its blood-brain barrier penetration and sub-nanomolar affinity enable targeted amyloid-beta reduction without impacting synaptic transmission at moderate exposures.

• I-BET151 (GSK1210151A): BET Inhibition and Disulfidptosis in

  2026-04-16

  Explore how I-BET151 (GSK1210151A) enables innovative interrogation of disulfidptosis and super-enhancer-driven transcription in cancer biology. This article offers a nuanced, assay-focused perspective that extends beyond standard BET inhibitor applications.

• LY294002: Precision PI3K Inhibition for Advanced Cell Signal

  2026-04-15

  LY294002 stands apart as a robust, cell-permeable PI3K/Akt/mTOR signaling pathway inhibitor, enabling researchers to dissect cancer, fibrosis, and autophagy pathways with unmatched specificity. Its reversible action and dual targeting of class I PI3K isoforms and BET bromodomain proteins empower versatile experimental designs and troubleshooting flexibility.

• PNU 74654: Wnt Signaling Pathway Inhibitor for Research Use

  2026-04-14

  PNU 74654 is a high-purity, small molecule Wnt signaling pathway inhibitor validated for precise modulation of Wnt/β-catenin signaling. It is crucial for investigating cell proliferation and differentiation in cancer and stem cell models. This article details its mechanism, evidence base, and critical workflow parameters.

444 records 20/30 page Previous Next First page 上5页 1617181920 下5页 Last page